Insert heading depending line on length; please delete delete. length; please delete other cover options once

Similar documents
Insert heading depending. cover options once. other cover options once you have chosen one. 20pt. Ref: N-SC/031

Specialised Services Commissioning Policy: CP34 Circumcision for children

Title: Male Circumcision Policy

Specialised Services Policy Position PP104

Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer

GAMETE STORAGE. Reviewing body Review date Version no

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Skull Base Tumour Treatment NHS Overseas Programme (Adult)

DRAFT FOR CONSULTATION. Clinical Commissioning Policy Proposition: Palliative radiotherapy for bone pain

Clinical Commissioning Policy Proposition: Pasireotide: An injectable medical therapy for the treatment of Cushing's disease

DRAFT FOR CONSULTATION. Clinical Commissioning Policy Proposition: Robotic assisted trans-oral surgery for throat and voice box cancers

Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV positive adults and adolescents

Clinical Commissioning Policy: Immune Tolerance Induction (ITI) for haemophilia A (all ages)

Clinical Commissioning Policy Statement: Eculizumab for atypical haemolytic uraemic syndrome. September 2013 Reference: E03/PS(HSS)/a.

Clinical Commissioning Policy: Auditory brainstem implant with congenital abnormalities of the auditory nerves of cochleae

Clinical Commissioning Policy Proposition: Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex

Clinical Commissioning Policy Proposition: Rituximab for cytopaenia complicating primary immunodeficiency

Policy Statement. Title/Topic: Hyaluronic Acid Injections for Osteoarthritis Date: April 2014 Reference: GM037

Clinical Commissioning Policy Proposition:

Clinical Commissioning Policy Proposition:

Commissioning Policy Individual Funding Request

Clinical Commissioning Policy Proposition: Selexipag in the treatment of Pulmonary Arterial Hypertension

DRAFT FOR POC BOARD Clinical Commissioning Policy Proposition: Rituximab in Connective Tissue Disease associated Interstitial Lung Disease (adults)

Clinical Commissioning Policy Proposition:

Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Clinical Commissioning Policy: Gemcitabine and capecitabine following surgery for pancreatic cancer (all ages)

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

Clinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer

Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO) Closure. April Reference: NHSCB/A09/PS/a

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P

Clinical Commissioning Policy: Rituximab for the treatment of idiopathic membranous nephropathy in adults

Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages) Reference: NHS England F03/P/b

Greater Manchester EUR Policy Statement

Clinical Commissioning Policy Proposition: Personalised External Aortic Root Support (PEARS) for surgical management of enlarged aortic root (adults)

Specialised Services Policy Position PP151

Clinical Commissioning Policy: Vagal Nerve Stimulation (VNS) December Reference : NHSCB/D4/c/7

School Hearing Screening Policy

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate

Reference: NHS England: 16022/P

PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist

Reference: NHS England B01X26

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation

Clinical Commissioning Policy Statement: Flow Diverting Devices for Intracranial Aneurysms. April Reference : NHSCB/D03/PS/a

Specialised Services Policy:

Clinical Commissioning Policy Proposition: Urethroplasty for benign urethral strictures in adult men

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Clinical Commissioning Policy Proposition: Treatments for Graft versus Host Disease (GvHD) following Haematopoietic Stem Cell Transplantation

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care

You said we did. Our Healthier South East London. Dedicated engagement events

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

Clinical Commissioning Policy Statement: Co-careldopa Intestinal Gel (Duodopa) December Reference : NHSCB/D4/c/3

Smoke Free Policy. Version 2.0

NO SMOKING POLICY. Organisational

Clinical Commissioning Policy Proposition:

NHS public health functions agreement

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

Clinical Commissioning Policy: Selexipag in the treatment of Pulmonary Arterial Hypertension

DRAFT FOR PUBLIC CONSULTATION. Clinical Commissioning Policy Proposition: Infliximab for the treatment of hidradenitis suppurativa

Pandemic influenza Recommendations on the use of antiviral medicines for pregnant women, women who are breastfeeding and children under the age of

Barnet Scrutiny Committee report 13 th October Barnet Sexual Health Strategy Dr Andrew Howe, Director of Public Health

Botulinum Toxin Type A Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Translation and Interpretation Policy

Specialised Services Policy: CP23 Vagal Nerve Stimulation

None Natalia Clifford, Public Health Consultant Tel: Summary

Title Use of Pre-Operative Tests for Elective Surgery Guideline. Department. Anaesthetics. Comment / Changes / Approval

Commissioning Policy. Treatment of Snoring. April 2010

abcdefghijklmnopqrstu

Consultation Guide: Specialised gynaecology surgery and complex urogynaecology conditions service specifications

Delivering first class mental health care services in south west London Committed to care, creating communities

NHS public health functions agreement

Specialised Services Policy: CP91 Extracorporeal Photophoresis (ECP) for the Treatment of Chronic Graft versus Host Disease in Adults

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

Aligning the Publication of Performance Data Statistics Consultation

An Undergraduate Syllabus for Urology. Produced on behalf of the British Association of Urological Surgeons. March 2012

OFFICIAL. Document Status. NHS England INFORMATION READER BOX

Commissioning Policy: Coventry and Rugby CCG (CRCCG)

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

FOR CHILDREN ATTENDING FOR EXODONTIA UNDER GENERAL ANAESTHETIC

Integrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014

Insulin Pumps and Glucose Monitors in Adults Policy

NHS public health functions agreement

OFFICIAL. Achieving World-Class Cancer Outcomes: Taking the strategy forward Equality and Health Inequalities Analysis. May

Commissioning Policy. The use of Acupuncture in the Management of Musculoskeletal Pain. July 2013

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group. Terms of Reference

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

Specialised Services Policy: CP24 Home Administered Parenteral Nutrition (HPN)

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups

18 September 2015 FERTILITY ASSESSMENT AND TREATMENT AMENDMENT CONSULTATION

Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei

Cardiac Rehabilitation: Costing Tool Guidance

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

PRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016

Fertility Services Commissioning Policy

31 December a programme of dates of meetings for Full Council, Policy Page: 241 Committees, and Area Committees for the twelve months commencing 1 May

Circumcision Guidelines for South Africa Submitted: 14 November 2006

Low back pain and sciatica in over 16s NICE quality standard

Transcription:

Insert heading depending Insert on Interim Insert heading line length; Clinical please Commissioning depending on line on length; please delete delete other Policy: on line line cover Circumcision length; please delete other cover options once once other cover options once you have chosen one. 20pt you you have have chosen one. one. 20pt 20pt Agreed: November 2013 Ref: N-SC010

NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information Nursing Policy Commissioning Development Finance Human Resources Publications Gateway Reference: 00585 Document Purpose Document Name Author Publication Date Target Audience Resources Interim Clinical Commissioning Policy: Circumcision NHS England/Operations Directorate/Direct Commissioning 19 November 2013 CCG Clinical Leaders, CCG Chief Officers, CSO Managing Directors, Care Trust CEs, Foundation Trust CEs, Medical Directors, NHS England Regional Directors, NHS England Area Directors, Directors of Finance, GPs, NHS Trust CEs Additional Circulation List #VALUE! Description Cross Reference Superseded Docs (if applicable) Action Required The set of non-specialised commissioning policies have been agreed by NHS England's Clinical Priority Advisory Group (CPAG) and approved by the Directly Commissioned Services Committee (DCSC) as interim policies for those populations we directly commission services for (namely the Serving Armed Forces & some families and those in detained settings) Timing / Deadlines (if applicable) Contact Details for further information Document Status Andy Bacon Assistant Head of Armed Forces Health Commissioning NHS England Skipton House, London SE1 6LH armedforceshealth@nhs.net 0 This is a controlled document. Whilst this document may be printed, the electronic version posted on the intranet is the controlled copy. Any printed copies of this document are not controlled. As a controlled document, this document should not be saved onto local or network drives but should always be accessed from the intranet

Interim Clinical Commissioning Policy Circumcision First published: November 2013 Prepared by Armed Forces Commissioning Policy Task and Finish Group Published by NHS England in electronic format only Gateway Reference: 00585

Contents Policy Statement. 4 Equality Statement... 4 Plain Language Summary... 4 1. Introduction..... 4 2. Criteria for commissioning... 5 3. Evidence Base... 6

Policy Statement NHS England will not commission treatments for Circumcision for personal, social, cultural or religious reasons in accordance with the criteria outlined in this document. In creating this policy NHS England has reviewed this clinical condition and the options for its treatment. It has considered the place of this treatment in current clinical practice, whether scientific research has shown the treatment to be of benefit to patients, (including how any benefit is balanced against possible risks) and whether its use represents the best use of NHS resources. This policy document outlines the arrangements for funding of this treatment for patients where NHS England directly commissions this service. Equality Statement NHS England has a duty to have regard to the need to reduce health inequalities in access to health services and health outcomes achieved as enshrined in the Health and Social Care Act 2012. NHS England is committed to ensuring equality of access and non-discrimination, irrespective of age, gender, disability (including learning disability), gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex (gender) or sexual orientation. In carrying out its functions, NHS England will have due regard to the different needs of protected equality groups, in line with the Equality Act 2010. This document is compliant with the NHS Constitution and the Human Rights Act 1998. This applies to all activities for which they are responsible, including policy development, review and implementation. Plain Language Summary Male circumcision is the surgical removal of the foreskin. Female circumcision is prohibited by the law. 1. Introduction Male Circumcision for personal, social, cultural and religious reasons is regarded as a procedure of low clinical priority and therefore not routinely funded by the Commissioner. Female Circumcision Female circumcision or female genital mutilation is prohibited by the law (The Prohibition of Female Circumcision Act 1995) and will therefore not be funded by the Commissioner.

2. Criteria for commissioning Policy: Circumcision is considered a low priority treatment and will only be provided for a small number of therapeutic reasons in line with these guidelines: 1. Absolute indications for circumcision: Penile malignancy. Traumatic foreskin injury where it cannot be salvaged. 2. Medical indications for circumcision: Balanitis Xerotica Obliterans (BXO) (chronic inflammation leading to a rigid fibrous foreskin). Severe recurrent attacks of Balanoposthis (recurrent bacterial infection of the glans and foreskin). Recurrent febrile UTIs with an abnormal urinary tract. Phimosis in adults leading to paraphimosis or difficulties in erection. The clinician proposing this intervention will make the decision to treat based on the criteria set out above. If the patient does not fully meet this criteria the clinician may submit an application for exceptional funding (Individual funding request policy, application form and contact details on NHS Internet http://www.england.nhs.uk/ourwork/d-com/policies/gp/) An annual audit will be completed to confirm that patients have been treated in accordance with these criteria. 3. Evidence Base 1. Statement from the British Association of Paediatric Urologists on behalf of the British Association of Paediatric Surgeons and the Association of Paediatric Anaesthetists. Management of Foreskin Conditions. 2007. http://www.rcsed.ac.uk/fellows/meflett/library/statements/circumcision2007.pdf 2. Hackett G, Kell P, Ralph D, Dean J, Price D, Speakman M, Wylie, K and for the British Society for Sexual Medicine (2008), British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction. The Journal of Sexual Medicine, 5:1841 1865. doi:10.1111/j.1743-6109.2008.00773.x. http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2008.00773.x/abstract

3 General Medical Council. Personal Beliefs and Medical Practice. March 2008. http://www.gmc-uk.org/static/documents/content/personal_beliefs.pdf 4. British Medical Association. The law and ethics of male circumcision. Guidance for doctors. June 2006. http://www.bma.org.uk/images/circumcision_tcm41-147277.pdf 5. The Royal College of Surgeons of England. Good Surgical Practice, February 2008. 6. Dr Peter Ball MB, B Chir and John Dalton BSc, MSc. Norm-UK. Clinical Guidelines for Phimosis. Last updated on 1 May 2008. http://www.normuk.org/phimosis_clinical_guidelines.html 7. Siegfried N, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database of Systematic Reviews 2009. DOI: 10.1002/14651858. CD003362.pub2. http://onlinelibrary.wiley.com/doi/10.1002/14651858.cd003362.pub2/pdf 8. Caryn L et al. Safety and efficacy of non therapeutic male circumcision: a systematic review Jan-Feb 2010; 8(1):64-72. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2807391/ 9. Black s Medical Dictionary. 42nd Edition. A & C Black. London. 2010. 10. The Prohibition of Female Circumcision Act 1995.